2026. Clinical Effectiveness of Dolutegravir-based Antiretroviral Therapy and its Determinants in Persons Living with HIV at a Kenyan Referral Hospital. The East and Central African Journal of Pharmaceutical Sciences. 27, 2 (May 2026), 44–53.